Faecalibacterium prausnitzii Supplementation Prevents Intestinal Barrier Injury and Gut Microflora Dysbiosis Induced by Sleep Deprivation
- PMID: 38674791
- PMCID: PMC11054126
- DOI: 10.3390/nu16081100
Faecalibacterium prausnitzii Supplementation Prevents Intestinal Barrier Injury and Gut Microflora Dysbiosis Induced by Sleep Deprivation
Abstract
Sleep deprivation (SD) leads to impaired intestinal barrier function and intestinal flora disorder, especially a reduction in the abundance of the next generation of probiotic Faecalibacterium prausnitzii (F. prausnitzii). However, it remains largely unclear whether F. prausnitzii can ameliorate SD-induced intestinal barrier damage. A 72 h SD mouse model was used in this research, with or without the addition of F. prausnitzii. The findings indicated that pre-colonization with F. prausnitzii could protect against tissue damage from SD, enhance goblet cell count and MUC2 levels in the colon, boost tight-junction protein expression, decrease macrophage infiltration, suppress pro-inflammatory cytokine expression, and reduce apoptosis. We found that the presence of F. prausnitzii helped to balance the gut microbiota in SD mice by reducing harmful bacteria like Klebsiella and Staphylococcus, while increasing beneficial bacteria such as Akkermansia. Ion chromatography analysis revealed that F. prausnitzii pretreatment increased the fecal butyrate level in SD mice. Overall, these results suggested that incorporating F. prausnitzii could help reduce gut damage caused by SD, potentially by enhancing the intestinal barrier and balancing gut microflora. This provides a foundation for utilizing probiotics to protect against intestinal illnesses.
Keywords: Faecalibacterium prausnitzii; intestinal barrier function; intestinal microflora; short chain fatty acids; sleep deprivation.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures







Similar articles
-
Faecalibacterium prausnitzii-derived microbial anti-inflammatory molecule regulates intestinal integrity in diabetes mellitus mice via modulating tight junction protein expression.J Diabetes. 2020 Mar;12(3):224-236. doi: 10.1111/1753-0407.12986. Epub 2019 Oct 30. J Diabetes. 2020. PMID: 31503404 Free PMC article.
-
Butyrate mediates anti-inflammatory effects of Faecalibacterium prausnitzii in intestinal epithelial cells through Dact3.Gut Microbes. 2020 Nov 9;12(1):1-16. doi: 10.1080/19490976.2020.1826748. Gut Microbes. 2020. PMID: 33054518 Free PMC article.
-
Faecalibacterium prausnitzii and a Prebiotic Protect Intestinal Health in a Mouse Model of Antibiotic and Clostridium difficile Exposure.JPEN J Parenter Enteral Nutr. 2018 Sep;42(7):1156-1167. doi: 10.1002/jpen.1053. Epub 2018 Jan 31. JPEN J Parenter Enteral Nutr. 2018. PMID: 29385239 Free PMC article.
-
Causal Relationship between Diet-Induced Gut Microbiota Changes and Diabetes: A Novel Strategy to Transplant Faecalibacterium prausnitzii in Preventing Diabetes.Int J Mol Sci. 2018 Nov 22;19(12):3720. doi: 10.3390/ijms19123720. Int J Mol Sci. 2018. PMID: 30467295 Free PMC article. Review.
-
The critical role of Faecalibacterium prausnitzii in human health: An overview.Microb Pathog. 2020 Dec;149:104344. doi: 10.1016/j.micpath.2020.104344. Epub 2020 Jun 11. Microb Pathog. 2020. PMID: 32534182 Review.
Cited by
-
Biochemical insight into gut microbial imbalance in Covid-19 and post vaccination heart attacks.World J Microbiol Biotechnol. 2025 Jun 25;41(7):206. doi: 10.1007/s11274-025-04431-6. World J Microbiol Biotechnol. 2025. PMID: 40555851
-
Microbiome, dysbiosis and use of probiotics in various diseases.World J Virol. 2025 Jun 25;14(2):99574. doi: 10.5501/wjv.v14.i2.99574. World J Virol. 2025. PMID: 40575647 Free PMC article. Review.
-
Gut Microbiome Interventions: From Dysbiosis to Next-Generation Probiotics (NGPs) for Disease Management.Probiotics Antimicrob Proteins. 2025 May 28. doi: 10.1007/s12602-025-10582-7. Online ahead of print. Probiotics Antimicrob Proteins. 2025. PMID: 40434505 Review.
-
Microbiome-Based Therapeutics for Insomnia.Int J Mol Sci. 2024 Dec 9;25(23):13208. doi: 10.3390/ijms252313208. Int J Mol Sci. 2024. PMID: 39684918 Free PMC article. Review.
-
Gut microbiota differences, metabolite changes, and disease intervention during metabolic - dysfunction - related fatty liver progression.World J Hepatol. 2025 Mar 27;17(3):103854. doi: 10.4254/wjh.v17.i3.103854. World J Hepatol. 2025. PMID: 40177201 Free PMC article. Review.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous